Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Given Consensus Recommendation of “Strong Sell” by Brokerages

Shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) have earned a consensus recommendation of “Strong Sell” from the nine ratings firms that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $28.00.

Several equities research analysts have recently weighed in on the company. Weiss Ratings lowered Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, May 7th. Citigroup reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Friday, April 24th. Jefferies Financial Group upgraded Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a research note on Friday, May 8th. Zacks Research lowered Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 27th. Finally, Wall Street Zen lowered Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th.

Fresenius Medical Care AG & Co. KGaA Trading Down 0.8%

Shares of FMS opened at $23.40 on Tuesday. Fresenius Medical Care AG & Co. KGaA has a 12-month low of $20.02 and a 12-month high of $28.86. The company has a quick ratio of 0.86, a current ratio of 1.20 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $12.64 billion, a price-to-earnings ratio of 12.31, a P/E/G ratio of 4.26 and a beta of 0.80. The stock’s 50-day moving average price is $22.32 and its 200 day moving average price is $22.83.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last issued its quarterly earnings results on Tuesday, March 31st. The company reported $1.05 earnings per share (EPS) for the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.90% and a net margin of 4.88%.The firm had revenue of $5.34 billion for the quarter. As a group, research analysts predict that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The business also recently disclosed an annual dividend, which was paid on Monday, June 8th. Stockholders of record on Friday, May 22nd were paid a $0.8716 dividend. The ex-dividend date was Friday, May 22nd. This represents a dividend yield of 402.0%. This is an increase from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio is currently 31.58%.

Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA

Large investors have recently bought and sold shares of the business. CIBC Private Wealth Group LLC grew its position in Fresenius Medical Care AG & Co. KGaA by 398.2% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 1,380 shares of the company’s stock worth $36,000 after acquiring an additional 1,103 shares during the last quarter. Arax Advisory Partners grew its position in Fresenius Medical Care AG & Co. KGaA by 121.6% during the 4th quarter. Arax Advisory Partners now owns 1,613 shares of the company’s stock worth $38,000 after acquiring an additional 885 shares during the last quarter. Kestra Advisory Services LLC bought a new stake in Fresenius Medical Care AG & Co. KGaA during the 4th quarter worth approximately $48,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Fresenius Medical Care AG & Co. KGaA during the 4th quarter worth approximately $58,000. Finally, Group One Trading LLC bought a new stake in Fresenius Medical Care AG & Co. KGaA during the 3rd quarter worth approximately $74,000. 8.37% of the stock is currently owned by institutional investors.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.